CODAC Health Lane
-
Services:
- Outpatient methadone/buprenorphine or naltrexone treatment
- Regular outpatient treatment
- Outpatient
- Health education services other than HIV/AIDS or hepatitis
- Smoking/vaping/tobacco cessation counseling
- Group counseling
- HIV or AIDS education, counseling, or support
- Individual counseling
- Substance use disorder education
- Hepatitis education, counseling, or support
- Relapse prevention
- Contingency management/motivational incentives
- Trauma-related counseling
- Motivational interviewing
- Substance use disorder counseling
- Cognitive behavioral therapy
- Telemedicine/telehealth therapy
- Brief intervention
- Aftercare/continuing care
- Naloxone and overdose education
- Discharge Planning
- Outcome follow-up after discharge
- Smoking not permitted
- State-financed health insurance plan other than Medicaid
- Federal, or any government funding for substance use treatment programs
- Medicaid
- Medicare
- Cash or self-payment
- Private health insurance
- Private non-profit organization
- Housing services
- Recovery coach
- Mentoring/peer support
- Assistance with obtaining social services
- Treatment for gambling disorder
- Transportation assistance
- Suicide prevention services
- Social skills development
- Early intervention for HIV
- Relapse prevention with naltrexone
- Accepts clients using MAT but prescribed elsewhere
- Federally-certified Opioid Treatment Program
- Buprenorphine maintenance
- Prescribes buprenorphine
- Prescribes naltrexone
- Maintenance service with medically supervised withdrawal after stabilization
- Young adults
- Adult women
- Adult men
- Naltrexone used in Treatment
- Buprenorphine used in Treatment
- Drug or alcohol urine screening
- TB screening
- STD testing
- Breathalyzer or blood alcohol testing
- HIV testing
- Testing for Hepatitis B (HBV)
- Drug and alcohol oral fluid testing
- Testing for Hepatitis C (HCV)
- Screening for substance use
- Screening for mental disorders
- Interim services for clients
- Screening for tobacco use
- Comprehensive substance use assessment
- Outreach to persons in the community
- Does not treat alcohol use disorder
- Vaping not permitted
- Female
- Male
- Buprenorphine (extended-release, injectable)
- Buprenorphine without naloxone
- Naltrexone (oral)
- Buprenorphine with naloxone
- Naltrexone (extended-release, injectable)
- Spanish
- Commission on Accreditation of Rehabilitation Facilities (CARF)
- State department of health
- Drug Enforcement Agency (DEA)
- SAMHSA certification for opioid treatment program (OTP)
- State Substance use treatment agency
- Substance use treatment
- Adults
- Young Adults
- In-network prescribing entity
Service Setting (e.g., Outpatient, Residential, Inpatient, etc.)
Education and Counseling Services
Treatment Approaches
Transitional Services
Facility Smoking Policy
Payment/Insurance/Funding Accepted
Facility Operation (e.g., Private, Public)
Recovery Support Services
Other Services
Ancillary Services
Type of Opioid Treatment
Special Programs/Groups Offered
Opioid Medications used in Treatment
Testing
Assessment/Pre-treatment
Type of Alcohol Use Disorder Treatment
Facility Vaping Policy
Gender Accepted
Pharmacotherapies
Language Services
License/Certification/Accreditation
Type of Care
Age Groups Accepted
External Opioid Medications Source